Showing results (201-210 of 289) with videos related to
Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell TransplantationSaurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.The Lancet. Oncology|October 4, 2011
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trialAmrita Krishnan, Marcelo C Pasquini, Brent Logan, et al.The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.Bone Marrow Transplantation|September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.Blood|July 29, 2004
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant RegistryCésar O Freytes, Fausto R Loberiza, J Douglas Rizzo, et al.Blood|October 22, 2013
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancyMary Eapen, John P Klein, Annalisa Ruggeri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L Scott, Marcelo C Pasquini, Brent R Logan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2012
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancyVanderson Rocha, Stephen Spellman, Mei-Jie Zhang, et al.Pageof 29